Success Metrics

Clinical Success Rate
96.4%

Based on 53 completed trials

Completion Rate
96%(53/55)
Active Trials
5(7%)
Results Posted
64%(34 trials)
Terminated
2(3%)

Phase Distribution

Ph phase_1
37
54%
Ph phase_2
8
12%
Ph phase_3
10
14%
Ph phase_4
11
16%
Ph not_applicable
1
1%

Phase Distribution

37

Early Stage

8

Mid Stage

21

Late Stage

Phase Distribution67 total trials
Phase 1Safety & dosage
37(55.2%)
Phase 2Efficacy & side effects
8(11.9%)
Phase 3Large-scale testing
10(14.9%)
Phase 4Post-market surveillance
11(16.4%)
N/ANon-phased studies
1(1.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.6%

53 of 56 finished

Non-Completion Rate

5.4%

3 ended early

Currently Active

5

trials recruiting

Total Trials

69

all time

Status Distribution
Active(5)
Completed(53)
Terminated(3)
Other(8)

Detailed Status

Completed53
unknown8
Recruiting3
Active, not recruiting2
Terminated2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
69
Active
5
Success Rate
96.4%
Most Advanced
Phase 4

Trials by Phase

Phase 137 (55.2%)
Phase 28 (11.9%)
Phase 310 (14.9%)
Phase 411 (16.4%)
N/A1 (1.5%)

Trials by Status

withdrawn11%
unknown812%
recruiting34%
active_not_recruiting23%
completed5377%
terminated23%

Recent Activity

Clinical Trials (69)

Showing 20 of 69 trialsScroll for more
NCT05735639Phase 4

THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)

Recruiting
NCT04045093Phase 4

Dabigatran for Mitral Stenosis Atrial Fibrillation

Active Not Recruiting
NCT07190430Phase 1

A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants

Active Not Recruiting
NCT06791187Phase 1

A Study in Healthy People to Test Whether BI 1291583 Influences the Amount of Dabigatran in the Body

Completed
NCT05959447Phase 1

Evaluation of the Potential Drug-drug Interactions Between Gemfibrozil or Dabigatran Etexilate and Camlipixant

Completed
NCT04099732Phase 1

A Study in Healthy Men to Test the Influence of BI 1358894 on the Amount of the Medicines Rosuvastatin and Dabigatran in the Blood

Completed
NCT00844415Phase 2

Safety and Tolerability of Dabigatran Etexilate in Adolescents

Completed
NCT04208061Phase 1

A Study of Darunavir in Combination With Cobicistat or Ritonavir, and Dabigatran Etexilate in Healthy Participants

Completed
NCT05673889Phase 1

A Study to Understand the Effect of a Study Medicine Called ARV-471 on Dabigatran Etexilate in Healthy Adults

Completed
NCT06329895Phase 1

A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy Participants

Completed
NCT06360055Not Applicable

Effect of Oral D-mannose Tablets on Pharmacokinetics of Dabigatranate in Healthy Adults

Recruiting
NCT04257032Phase 1

A Study in Healthy Men to Test the Influence of BI 1323495 on the Amount of the Medicines Rosuvastatin and Dabigatran in the Blood

Completed
NCT04749914Phase 1

A Study of Lasmiditan in Healthy Volunteers

Completed
NCT03492437Phase 1

Effect of Tepotinib on the PK of the P-gp Substrate Dabigatran Etexilate

Completed
NCT05347979Phase 1

Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants

Completed
NCT05438303Phase 1

Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers

Completed
NCT05471817Phase 1

A Study to Learn How the Study Drug Elinzanetant (BAY 3427080) Affects the Way the Drug Dabigatran Moves Into, Through and Out of the Body in Healthy Male and Female Participants

Completed
NCT05480475Phase 1

A Study to Examine the Effect of Daridorexant on the Way the Body Absorbs, Distributes, and Gets Rid of Dabigatran and Rosuvastatin in Healthy Male Subjects

Completed
NCT05368805Phase 1

Fruquintinib DDI Study With P-gp and BCRP Substrates

Completed
NCT04695106Phase 4

Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI

Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
69